Exchange: NASDAQ·Updated 07:30 PM EDT

ATTO Attovia Therapeutics Inc.

$13.88
$0.05
(0.36%)
Today
Closed $13.88
$0.00
(0.00%)
After Hours
EarningsNov 11
Mkt Cap$633.64M
Vol224,637.00

About ATTO

Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
47

Neutral Sentiment

How do you feel about ATTO?

Advertisement|Remove ads.